The International Partnership for Microbicides, IPM has welcomed a positive opinion from the European Medicines Agency on a monthly vaginal ring for use by women of ages between eighteen and older in developing countries to reduce their risk of HIV infection. The vaginal ring is the first long-acting HIV prevention product and is designed to help address women's need for new methods given the persistently high rates of HIV they face, especially in sub-Saharan Africa.
GUEST: Dr. Zeda Rosenberg – CEO of the International Partnership for Microbicides (USA)